UA107466C2 - Спосіб покращення біодоступності латанопросту - Google Patents
Спосіб покращення біодоступності латанопростуInfo
- Publication number
- UA107466C2 UA107466C2 UAA201200886A UAA201200886A UA107466C2 UA 107466 C2 UA107466 C2 UA 107466C2 UA A201200886 A UAA201200886 A UA A201200886A UA A201200886 A UAA201200886 A UA A201200886A UA 107466 C2 UA107466 C2 UA 107466C2
- Authority
- UA
- Ukraine
- Prior art keywords
- latanoprost
- improving bioavailability
- organic amine
- eye drop
- bioavailability
- Prior art date
Links
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 title abstract 4
- 229960001160 latanoprost Drugs 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 150000001412 amines Chemical class 0.000 abstract 2
- 239000003889 eye drop Substances 0.000 abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010030043 Ocular hypertension Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Винахід стосується способу покращення офтальмологічної біодоступності латанопросту за допомогою додавання від 0,1 до 1 % (мас./об.) трометамолу до водної композиції очних крапель, яка містить від 0,0025 до 0,005 % (мас./об.) латанопросту, де водна композиція очних крапель з латанопростом не містить консервантів, причому співвідношення латанопрост/трометамол в композиції складає не менше ніж 0,013.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09397519A EP2269575A1 (en) | 2009-06-30 | 2009-06-30 | Method for improving bioavailability of latanoprost |
PCT/JP2010/004179 WO2011001634A1 (en) | 2009-06-30 | 2010-06-23 | Method for improving bioavailability of latanoprost |
Publications (1)
Publication Number | Publication Date |
---|---|
UA107466C2 true UA107466C2 (uk) | 2015-01-12 |
Family
ID=41137869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201200886A UA107466C2 (uk) | 2009-06-30 | 2010-06-23 | Спосіб покращення біодоступності латанопросту |
Country Status (12)
Country | Link |
---|---|
US (1) | US20120107376A1 (uk) |
EP (2) | EP2269575A1 (uk) |
JP (1) | JP5695580B2 (uk) |
KR (1) | KR20120095341A (uk) |
CN (1) | CN102802633B (uk) |
CA (1) | CA2766269C (uk) |
EA (1) | EA022390B1 (uk) |
HK (1) | HK1172849A1 (uk) |
MY (1) | MY157434A (uk) |
SG (1) | SG176800A1 (uk) |
UA (1) | UA107466C2 (uk) |
WO (1) | WO2011001634A1 (uk) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR1008483B (el) * | 2013-12-23 | 2015-05-12 | Rafarm Α.Ε.Β.Ε., | Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης |
WO2018033854A1 (en) | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5040706A (en) * | 1989-03-17 | 1991-08-20 | Insite Vision, Inc. | Liquid droplet dispensing apparatus |
JPH03146881A (ja) | 1989-11-01 | 1991-06-21 | Fanuc Ltd | プリント基板の保持フレームの着脱構造 |
JPH0689576B2 (ja) | 1989-12-30 | 1994-11-09 | 株式会社第一ホーム | 根太固定装置 |
JPH042364A (ja) | 1990-04-19 | 1992-01-07 | Olympus Optical Co Ltd | 瘻孔形成管 |
DE4027320C2 (de) | 1990-08-29 | 1993-09-30 | Ursapharm Arzneimittel Gmbh | Fluid-Abgabeeinrichtung für keimfreies Fluid |
JP3659801B2 (ja) | 1998-04-21 | 2005-06-15 | キッセイ薬品工業株式会社 | トラニラスト水溶液製剤 |
EP1321144B1 (en) | 2000-09-13 | 2010-12-08 | Santen Pharmaceutical Co., Ltd. | Eye drops |
US20030055052A1 (en) | 2000-11-10 | 2003-03-20 | Stefan Peters | FAP-activated anti-tumor compounds |
TW586946B (en) | 2000-12-22 | 2004-05-11 | Novartis Ag | Process to improve stability |
US7074827B2 (en) | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
PL1808170T3 (pl) | 2004-11-05 | 2011-12-30 | Senju Pharma Co | Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową |
JP2006187602A (ja) | 2004-12-09 | 2006-07-20 | Santen Pharmaceut Co Ltd | 分子内にフッ素原子を有するプロスタグランジン含有製品 |
WO2007015510A1 (ja) * | 2005-08-02 | 2007-02-08 | Santen Pharmaceutical Co., Ltd. | 熱的に不安定な薬物の分解抑制方法 |
DK1795183T3 (da) * | 2005-12-09 | 2009-10-19 | Teva Pharma | Vandige dispersioner og oplösninger af vanskeligt oplöselige forbindelser og fremgangsmåder til deres fremstilling |
EP2123278B1 (en) * | 2007-02-07 | 2013-01-09 | Teika Pharmaceutical Co., Ltd. | Eye drop preparation comprising latanoprost |
TWI465236B (zh) | 2007-03-13 | 2014-12-21 | 參天製藥股份有限公司 | 含有吡諾克辛之懸浮型水性液劑 |
EP2167546A1 (en) * | 2007-07-11 | 2010-03-31 | Ophthalmopharma AG | Complexes of prostaglandin derivatives and monosubstituted, charged beta-cyclodextrins |
JP5253775B2 (ja) * | 2007-08-10 | 2013-07-31 | 科研製薬株式会社 | ラタノプロスト点眼剤 |
-
2009
- 2009-06-30 EP EP09397519A patent/EP2269575A1/en not_active Withdrawn
-
2010
- 2010-06-23 US US13/381,631 patent/US20120107376A1/en not_active Abandoned
- 2010-06-23 SG SG2011091741A patent/SG176800A1/en unknown
- 2010-06-23 WO PCT/JP2010/004179 patent/WO2011001634A1/en active Application Filing
- 2010-06-23 MY MYPI2011006155A patent/MY157434A/en unknown
- 2010-06-23 JP JP2011551134A patent/JP5695580B2/ja not_active Expired - Fee Related
- 2010-06-23 CA CA2766269A patent/CA2766269C/en not_active Expired - Fee Related
- 2010-06-23 UA UAA201200886A patent/UA107466C2/uk unknown
- 2010-06-23 EP EP10793808.6A patent/EP2448589A4/en not_active Withdrawn
- 2010-06-23 EA EA201270097A patent/EA022390B1/ru not_active IP Right Cessation
- 2010-06-23 KR KR1020127001350A patent/KR20120095341A/ko active Search and Examination
- 2010-06-23 CN CN201080028960.9A patent/CN102802633B/zh not_active Expired - Fee Related
-
2013
- 2013-01-07 HK HK13100192.1A patent/HK1172849A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2012532091A (ja) | 2012-12-13 |
CN102802633B (zh) | 2016-01-20 |
US20120107376A1 (en) | 2012-05-03 |
HK1172849A1 (zh) | 2013-05-03 |
EA201270097A1 (ru) | 2012-05-30 |
EP2448589A4 (en) | 2013-04-17 |
SG176800A1 (en) | 2012-01-30 |
WO2011001634A1 (en) | 2011-01-06 |
CN102802633A (zh) | 2012-11-28 |
EA022390B1 (ru) | 2015-12-30 |
CA2766269C (en) | 2018-04-03 |
EP2448589A1 (en) | 2012-05-09 |
CA2766269A1 (en) | 2011-01-06 |
KR20120095341A (ko) | 2012-08-28 |
EP2269575A1 (en) | 2011-01-05 |
JP5695580B2 (ja) | 2015-04-08 |
MY157434A (en) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA102257C2 (uk) | Офтальмологічний водний розчин для лікування очної гіпертензії та глаукоми | |
MY175318A (en) | Androgen composition for treating an opthalmic condition | |
MX358176B (es) | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea. | |
MX2013010039A (es) | Composicion oftalmica de alta concentracion de olopatadina. | |
EA201291236A1 (ru) | Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10 | |
EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
EA201290498A1 (ru) | Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения | |
UA102251C2 (uk) | Похідні амінодигідротіазину як інгібітори васе для лікування хвороби альцгеймера | |
EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
IN2014KN00948A (uk) | ||
MX359854B (es) | Anticuerpos anti-cxcr3. | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
MY170922A (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
UA113627C2 (xx) | Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування | |
WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
MX2014000781A (es) | Dosis combinada fija de bimatoprost y brimonidina. | |
MY159244A (en) | Method of reducing intraocular pressure in humans | |
WO2012016000A3 (en) | Preservative free brimonidine and timolol solutions | |
MX2013008699A (es) | Compuestos para reducir la produccion de beta-amiloide. | |
MY160383A (en) | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension | |
BR112012017319A2 (pt) | composições e métodos para abaixar a pressão intraocular | |
MY157434A (en) | Method for improving bioavailability of latanoprost | |
UA103197C2 (uk) | Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами | |
WO2010046865A3 (en) | Ophthalmic administration of a composition including brimonidine as a mist |